Citation Impact
Citing Papers
[21] Thioredoxin as a fusion partner for production of soluble recombinant proteins in Escherichia coli
2000
Inhibition of E6-induced Degradation of its Cellular Substrates by Novel Blocking Peptides
2003
The human papillomavirus E7 protein as a transforming and transactivating factor
1993
Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines
1999
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
Human papillomaviruses, cervical cancer and cell polarity
2008
Directed enzyme evolution
2001 StandoutNobel
Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells
2004 StandoutNobel
The Human Papillomavirus E6 protein and its contribution to malignant progression
2001
Viruses in human cancers
1999 StandoutNobel
Presence of Human Papilloma Virus Type 16 DNA Sequences in Human Nonmelanoma Skin Cancers
1991
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
1990 Standout
The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells
2009
The role of the E6-p53 interaction in the molecular pathogenesis of HPV
1999
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
1999 Standout
Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue
2000 StandoutNobel
Reduction of Yellow Fever Virus Mouse Neurovirulence by Immunization with a Bacterially Synthesized Non-structural Protein (NS1) Fragment
1988
Characterization of Events during the Late Stages of HPV16 Infectionin VivoUsing High-Affinity Synthetic Fabs to E4
1997 StandoutNobel
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
Serum Antibody against Unfused Recombinant E7 Protein of Human Papillomavirus Type 16 in Cervical Cancer Patients
1995
HPV-18 immortalization of human keratinocytes
1989
Viruses in human cancers
1999 StandoutNobel
Human papillomavirus type 16 E7 protein expressed in Escherichia coli and monkey COS-1 Cells: Immunofluorescence detection of the nuclear E7 protein
1989
Human papillomavirus and cervical cancer
2007 Standout
Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6.
1998
The papillomavirus E6 proteins
1998
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
HIV-1 reverse transcriptase: crystallization and analysis of domain structure by limited proteolysis
1988
Human papillomavirus type 16 and 18 gene expression in cervical neoplasias
1992
Epigenetic modifications and human disease
2010 Standout
Selective down-regulation of human papillomavirus transcription by 2-deoxyglucose
1998 StandoutNobel
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
Cellular transformation by papilomavirus oncorproteins
1993
Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex
1999 StandoutNobel
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
2005 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Comparison of the in vitro transforming activities of human papillomavirus types.
1988
A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter
1995 StandoutNobel
Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines
1991 StandoutNobel
Negative regulation of Rb expression by the p53 gene product.
1992
Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription.
1992
Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype.
1991
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
2001 StandoutNobel
Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras.
1989
Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1
1991 StandoutNobel
Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions.
1991 StandoutNobel
Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor
1992 StandoutScience
Inhibition of p53 DNA binding by human papillomavirus E6 proteins
1994
Transformation of human cells by oncogenic viruses supports permissiveness for parvovirus H-1 propagation
1989 StandoutNobel
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.
1989 Standout
Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells
1990 StandoutNobel
Transcriptional control of human p53-regulated genes
2008 Standout
Selective suppression of human papillomavirus transcription in non-tumorigenic cells by 5-azacytidine.
1988 StandoutNobel
Human Papillomavirus and Cervical Cancer
2003 Standout
Increased Incidence of Squamous Cell Carcinomas in Mastomys natalensis Papillomavirus E6 Transgenic Mice during Two-Stage Skin Carcinogenesis
2004 StandoutNobel
Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus.
1990
The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes
1989
The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography.
2002
Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription
1997 StandoutNobel
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
1992 Standout
Viruses in Human Cancers
1991 StandoutScienceNobel
Intracellular localization and DNA-binding properties of human papillomavirus type 18 E6 protein expressed with a baculovirus vector
1989
Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells.
1992 StandoutNobel
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids
1994 StandoutNobel
Immunization with nonstructural proteins promotes functional recovery of alphavirus-infected neurons
1997 StandoutNobel
Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells.
1991 StandoutNobel
Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer
1992
Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product
1991
Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18
1990
A Synthetic E7 Gene of Human Papillomavirus Type 16 That Yields Enhanced Expression of the Protein in Mammalian Cells and Is Useful for DNA Immunization Studies
2003 StandoutNobel
c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination
2001 StandoutNobel
An antigen chimera of poliovirus induces antibodies against human papillomavirus type 16
1990
Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells
1989
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
1990 StandoutScience
Assembly of an Active Group II Intron−Maturase Complex by Protein Dimerization
2004 StandoutNobel
Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes
1994 StandoutNobel
Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1.
1992 StandoutNobel
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
1992 Standout
The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product
1989 StandoutScience
Works of Paul Spence being referenced
Structure-Activity Relationships of the Kvβ1 Inactivation Domain and Its Putative Receptor Probed Using Peptide Analogs of Voltage-gated Potassium Channel α- and β-Subunits
1998
The Expression of Human Papillomavirus Type 18 E6 Protein in Bacteria and the Production of Anti-E6 Antibodies
1986
Identification of Human Papillomavirus Type 18 E6 Polypeptide in Cells Derived from Human Cervical Carcinomas
1987